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Introduction
Secreted signaling proteins, such as BMPs, Wnts, Hedgehog, 
and FGFs, play key roles in animal development. Although it is 
established that reception of these molecules on the cell sur-
face is mediated by heparan sulfate proteoglycans (HSPGs), 
the mechanism producing selective binding of proteins to hep-
aran sulfate (HS) in a growth factor–rich environment remains 
a fundamental question. HS is synthesized as disaccharide 
polymers, which then undergoes a series of modifi  cation events 
including N, 2-O, 6-O, and 3-O sulfation. A number of in vitro 
studies showed that interactions between HS and various 
growth factors require unique HS structures in which 2-O and 
6-O sulfate groups contribute to generate specifi  c sulfation 
  patterns (for reviews see Nakato and Kimata, 2002; Habuchi et al., 
2004). Crystallographic studies also supported this  biochemical 
evidence, showing that the 2-O and 6-O sulfate groups form 
hydrogen bonds with heparin binding residues of FGFs and/or 
FGF receptors (FGFRs) to induce dimerization of FGFRs 
(Schlessinger et al., 2000). Thus, in vitro studies showed that 
specifi  c sulfation patterns on HS have critical roles in its selec-
tive binding to ligand proteins. However, the in vivo impor-
tance of these sulfation events is poorly understood.
FGF signaling regulates tracheal system formation in 
Drosophila (Klambt et al., 1992; Sutherland et al., 1996). The 
tracheal precursor cells express Breathless (Btl), a Drosophila 
FGF receptor, and migrate toward regions expressing Branch-
less (Bnl; a Drosophila FGF) to form primary branches in the 
embryo. FGF also controls the formation of the adult tracheal 
system, the air sac, which develops from a group of cells called 
“tracheoblasts” in the wing disc (Sato and Kornberg, 2002). 
A previous study showed that Btl-dependent activation of MAP 
kinase relies on sulfateless (sfl  ), which encodes N-deacetylase/
N-sulfotransferase (NDST), indicating that HS has a crucial 
role in these processes (Lin et al., 1999). Because the reaction 
catalyzed by NDST is the fi  rst step in HS modifi  cation and is 
critical for subsequent reactions, mutation of sfl   results in the 
production of sugar chains with no sulfation (Toyoda et al., 
2000). To determine what structural features of HS are required 
for regulating FGF signaling, we characterized functions of 
HS 2-O sulfotransferase (Hs2st) and HS 6-O sulfotransferase 
(Hs6st) genes during tracheal development.
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S
peciﬁ  c sulfation sequence of heparan sulfate (HS) 
contributes to the selective interaction between HS 
and various proteins in vitro. To clarify the in vivo 
importance of HS ﬁ   ne structures, we characterized the 
functions of the Drosophila HS 2-O and 6-O sulfotrans-
ferase (Hs2st and Hs6st) genes in FGF-mediated tracheal 
formation. We found that mutations in Hs2st or Hs6st 
had unexpectedly little effect on tracheal morphogenesis. 
Structural analysis of mutant HS revealed not only a loss 
of corresponding sulfation, but also a compensatory in-
crease of sulfation at other positions, which maintains the 
level of HS total charge. The restricted phenotypes of Hsst 
mutants are ascribed to this compensation because FGF 
signaling is strongly disrupted by Hs2st; Hs6st double 
  mutation, or by overexpression of 6-O sulfatase, an extra-
cellular enzyme which removes 6-O sulfate groups without 
increasing 2-O sulfation. These ﬁ  ndings suggest that the 
overall sulfation level is more important than strictly de-
ﬁ  ned HS ﬁ  ne structures for FGF signaling in some devel-
opmental contexts.
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Results and discussion
We generated Hs2st and Hs6st mutations by imprecise P-element 
excision (Fig. S1, available at http://www.jcb.org/cgi/content/
full/jcb.200603129/DC1). The excision alleles, Hs2st
d267 and 
Hs6st
d770, delete their respective coding regions, and lethality 
of Hs2st
d267 and Hs6st
d770 homozygotes was equivalent to that 
of their defi   ciency transheterozygotes, indicating that these 
mutants are null alleles for each gene. Despite the previous 
  implication of 2-O and 6-O sulfate groups in the binding of HS 
to many growth factors in vitro (for reviews see   Nakato and 
Kimata, 2002; Habuchi et al., 2004), Hs2st and Hs6st mutants 
showed only moderate effects on development. Zygotic Hs2st 
and Hs6st mutants survive to the adult stage without showing ob-
vious morphological defects. We also generated embryos in which 
both maternal and zygotic Hsst gene activities are eliminated 
(“Hsst null embryos”). Although such null mutations caused par-
tial lethality during development, signifi  cant fractions of these 
null mutants survive to the adult stage without visible phenotypes. 
This fi  nding demonstrated that loss of   either 2-O or 6-O sulfation 
does not completely disrupt normal development.
Because 2-O and 6-O sulfations are critical for FGF-HS 
binding in vitro (for reviews see Nakato and Kimata, 2002; 
  Habuchi et al., 2004), we focused our efforts on the function of 
Hs2st and Hs6st in btl-mediated tracheal migration. The tra-
cheal system develops from clusters of ectodermal cells that in-
vaginate into the underlying mesoderm and form ten sacs on 
each side of the embryo. Each sac forms six primary branches 
by stereotypical cell migration. Some of these branches, such as 
the dorsal trunk, fuse with corresponding branches in neigh-
boring segments to form a continuous tracheal network (Fig. 1 A). 
In btl or sfl   mutants, the tracheal cells remain clustered at the 
site of the tracheal pits without migration (Klambt et al., 1992; 
Lin et al., 1999). In contrast, we found that maternal and zygotic 
null mutations of Hs2st or Hs6st had only limited effects on tra-
cheal development (Fig. 1, D–F). Remarkably, only 9% of Hs2st 
null embryos exhibited a stalled migration of the dorsal branch 
(Fig. 1 D). A fraction (39%) of Hs6st null embryos exhibited 
tracheal defects (Fig. 1 E). In these mutant embryos tracheal 
migration is incomplete, as revealed by the presence of large 
gaps in the dorsal trunks, as well as stalled tracheal branches. 
The migration defects in these embryos were observed in all 
primary branches, but most commonly in the dorsal branch and 
the dorsal trunk. Surprisingly, however, tracheal morphology 
was indistinguishable from that of wild-type embryos in the 
  remaining 61% of the embryos (Fig. 1 F).
Next, we examined whether Hs2st and Hs6st mutations 
affect the formation of the tracheoblast in the wing disc. Normal 
development of tracheoblasts was observed in all Hs2st and 
most Hs6st mutants we examined (Fig. 1, I and J), although the 
tracheoblast was slightly reduced in size in a small fraction 
(18%) of Hs6st mutant discs (Fig. 1, K and L). The small tra-
cheoblast phenotype of Hs6st mutants was completely rescued 
by Hs6st expression from a UAS-Hs6st transgene (Fig. 1 M). 
Thus, null mutations in Hs2st and Hs6st do not completely 
block btl-mediated tracheal formation, showing that Hs2st and 
Hs6st mutant animals can produce HS chains that retain a con-
siderable level of activity to mediate FGF signaling.
Figure 1.  Tracheal phenotypes of Hs2st and Hs6st 
mutants.  (A–F) Embryonic tracheal phenotypes in 
Hs2st and Hs6st mutants. Tracheal phenotypes were 
observed in stage 14 embryos using enhancer trap 
activity for the trachealess (trh) gene. (A) Wild-type 
embryos. Hs2st
d267 (B) or Hs6st
d770 (C) zygotic muta-
tions do not affect tracheal development. (D) Hs2st
d267 
maternal and zygotic null mutations have little effect 
on tracheal morphology except for migration defects 
of the dorsal branch (arrowhead) in 9% of these 
  embryos. (E) 39% (20 out of 51) of Hs6st
d770 null em-
bryos showed tracheal migration defects. Abnormal-
ities were commonly observed in the dorsal trunk 
(arrows) and the dorsal branch (arrowheads). The 
other embryos (61%) showed normal tracheal mor-
phology (F). (G–M) Tracheoblast formation in Hs2st
d267 
and Hs6st
d770 wing discs. Tracheoblasts were visualized 
by UAS-GFP driven by btl-Gal4 (G, I, J, K, L, and M) 
or  trh enhancer trap expression (H). (G) Wild-type 
  tracheoblasts. sﬂ  
9B4 mutation causes loss of tracheo-
blasts (H). Overall morphology of the tracheoblasts 
was not affected in all Hs2st
d267 (I) and most Hs6st
d770 
(J) mutants. Two examples are shown for Hs6st
d770 
  mutant discs with smaller tracheoblasts (K and L). This 
phenotype was completely rescued by Hs6st expres-
sion in btl-Gal4/UAS-Hs6st; Hs6st
d770 (M). FUNCTION OF 2-O AND 6-O SULFATED HS IN FGF SIGNALING • KAMIMURA ET AL. 775
The modest tracheal phenotypes of the Hs2st and Hs6st 
null mutants clearly challenge a current view on the role of HS 
fi  ne structures: numerous biochemical analyses have demon-
strated that 2-O and 6-O sulfate groups are critically required for 
the HS-growth factor interaction (for reviews see Nakato and 
Kimata, 2002; Habuchi et al., 2004). One possible reason for the 
restricted phenotypes of these mutants is that the sulfation pat-
terns of mutant HS are altered to restore the growth factor 
  signaling. To examine this possibility, disaccharide profi  les of HS 
from Hs2st and Hs6st mutant animals were determined using 
fl  uorometric post-column HPLC (Toyoda et al., 2000). In wild-
type adult fl  ies, the disaccharide composition of HS showed a 
similar pattern to representative vertebrate tissues (Toyoda et al., 
2000). In contrast, HS samples from Hs2st or Hs6st zygotic 
  mutant adults showed a complete loss of the corresponding dis-
accharide units, confi  rming the amorphic nature of these mutant 
alleles. Signifi   cantly, HS disaccharides from Hs2st mutants 
showed not only a loss of 2-O sulfated disaccharide units, but 
also a remarkable increase of 6-O sulfated disaccharides. Simi-
larly, levels of the 2-O sulfated disaccharides are strikingly 
 elevated  in  Hs6st mutants. As a result, the level of total sulfate 
groups on HS was not affected in each case, and the total charge 
of HS in Hs2st and Hs6st mutants was almost wild type (Fig. 2). 
These results strongly suggested the existence of a compensa-
tion mechanism that adjusts the levels of sulfate groups when 
a component of the HS-modifi   cation machinery is lacking. 
  Importantly, similar compensation of HS sulfation has also been 
observed in Hs2st mutant mice (Merry et al., 2001), implicating 
this system as a general property of the HS modifi  cation ma-
chinery that is widely conserved across species. Thus, the unal-
tered charge levels on HS in the Drosophila Hsst mutants may 
contribute to their mild phenotypes, and the function of the 2-O 
sulfate group seems to be replaceable with that of the 6-O sul-
fate group, and vice versa, in some developmental contexts.
To confi  rm the hypothesis that the compensatory increase 
of sulfation weakens Hs2st and Hs6st mutant phenotypes, we 
performed several sets of experiments in which the compensa-
tion was blocked. First, we examined the tracheal phenotypes 
of Hs2st; Hs6st double-mutant animals. In these animals, the 
compensation of HS sulfation would not occur due to the ab-
sence of both counterparts (Hs2st and Hs6st) that complement 
each other in Hs2st or Hs6st single mutants. In fact, despite the 
relatively normal development of the single mutants, the Hs2st; 
Hs6st zygotic double mutants are completely lethal. In wild-
type embryos, tracheal precursor cells invaginate in each 
hemisegment at stage 11 (Fig. 3 A), and migrate and elongate to 
form primary branches at stage 12 (Fig. 3 D). One of these 
branches, the dorsal trunk, fuses with ones in the neighboring 
segments at stage 14 (Fig. 3 G). Although invagination seems to 
occur normally in the Hs2st; Hs6st embryos, they exhibit sev-
eral characteristic defects in branching morphogenesis. First, 
mutant tracheal precursor cells failed to migrate to form the 
primary branches (Fig. 3 H). This defect resembles that of btl or 
sfl   mutants (Klambt et al., 1992; Lin et al., 1999). Second, clus-
ters of mutant tracheal cells tend to extend dorsally and ven-
trally, forming long, skinny sacs of tracheal precursor cells of 
various size (Fig. 3, E and H). Finally, 16% of mutant embryos 
showed fusion of the tracheal sacs to those in the neighboring 
segments (Fig. 3, C and I).
We asked whether FGF signaling is impaired in these ani-
mals using an antibody that specifi  cally recognizes the diphos-
phorylated form of MAP kinase (dpMAPK; Gabay et al., 1997). 
In wild-type embryos, dpMAPK is detected in the tracheal plac-
odes at stage 10, refl  ecting activation of DER, a Drosophila 
EGF receptor (Gabay et al., 1997). This dpMAPK signal was 
not diminished in the Hs2st; Hs6st embryos, showing that DER 
signaling is not affected by the double mutations (Fig. 3, K, K’; 
Fig. S2 A, available at http://www.jcb.org/cgi/content/full/
jcb.200603129/DC1). At stage 12, wild-type embryos show a 
strong dpMAPK signal in the migrating tip cells of each pri-
mary branch due to activation of FGF signaling (Gabay et al., 
1997). In contrast, the btl-dependent MAPK activation in the tip 
cells is disrupted in the Hs2st; Hs6st embryos (Fig. 3, M, M’; 
Fig. S2 A). In situ RNA hybridization experiments revealed that 
bnl expression is not altered in the double mutant embryos (Fig. 
S2 C), confi  rming that the branching defects observed in the 
Figure 2.  HS disaccharide proﬁ  ling of Hs2st and Hs6st mutants. (Left) Representative HPLC chromatograms of wild-type (black), Hs2st
d267 (pink), and 
Hs6st
d770 (green) mutant HS. (Middle) Graphical depiction of disaccharide composition in these mutants, represented as percentage of total HS. (Right) Total 
levels of sulfate groups in Hs2st
d267 and Hs6st
d770 mutants. The value indicates the ratio of total sulfate groups in mutants to that in wild type.JCB • VOLUME 174 • NUMBER 6 • 2006  776
double mutants are caused by disruption of FGF reception 
but not FGF expression. These results showed that HS with 
 neither  2-O nor 6-O sulfate groups lost the ability to mediate 
Btl signaling.
Next, we examined whether simultaneous loss of both 
2-O and 6-O sulfate groups affects tracheoblast formation in the 
wing disc. Because Hs2st; Hs6st mutants die during embryo-
genesis, we analyzed Hs2st homozygous animals bearing a 
transgene that expresses double-stranded RNA for Hs6st 
(Hs6st RNAi) under a specifi  c Gal4 driver (Kennerdell and 
Carthew, 2000). Tracheoblast development was not affected 
either by homozygosity of the Hs2st null mutation (Fig. 1 I) or 
by expression of the Hs6st RNAi construct (unpublished data). 
In contrast, Hs6st RNAi in btl-expressing (tracheal) cells in 
Hs2st homozygous mutant background completely blocked 
the formation of the tracheoblast (Fig. 3 O). No such effect 
was observed, however, when the Hs6st RNAi was induced 
in bnl-expressing (nontracheal) cells in the same mutant back-
ground (Fig. 3 P). Thus, HS requires either 2-O or 6-O sulfate 
groups for reception of FGF, but these modifi  cations are not 
essential in the FGF-expressing cells. Collectively, tracheal 
  development could occur in Hs2st or Hs6st single mutants, 
but not in the double mutants. These fi  ndings demonstrated 
  redundant roles of 2-O and 6-O sulfate groups of HS in FGF 
signaling during tracheal development.
As another approach to reduce 6-O sulfation without 
  inducing an increase of other sulfation events, we examined 
the effects of overexpressing Sulf1, a Drosophila extracellular 
sulfatase (CG6725), on FGF signaling. Vertebrate Sulf genes 
encode secreted HS 6-O sulfatases, which remove sulfate 
groups from the HS on the cell surface (Dhoot et al., 2001). 
Because Sulf1 seems to modify HS fi  ne structure extracellu-
larly, and we hypothesized that compensatory changes in sul-
fation occur during HS biosynthesis in the Golgi, we expected 
that the number of sulfate groups on HS in Sulf1-expressing 
animals would decrease. Indeed, this was the case. Disac-
charide profi  ling of HS from actin-Sulf1 animals showed a
signifi  cant reduction in the level of 6-O sulfation without the 
compensatory increase of other sulfate groups (Fig. 4 A). 
As a result, the total sulfate level is reduced in these animals 
to 76.3% of the wild-type level. Importantly, overexpression 
of Sulf1 had stronger effects on viability and FGF-mediated 
 tracheogenesis  than  Hs6st mutations. actin-Sulf1 animals 
showed 71% lethality (unpublished data). The tracheoblast 
was dramatically reduced in size by expression of Sulf1 in 
btl-expressing (tracheal) cells (Fig. 4 B). The fact that Sulf1-
  expressing animals show more severe phenotypes than Hs6st 
null mutants strongly suggests that the compensatory increase 
of 2-O sulfation in Hs6st mutant HS restores the ability to me-
diate FGF signaling. From these fi  ndings, we conclude that 
biosynthesis and modifi  cation of HS show a striking fl  exibility. 
In the absence of a component of the HS-modifi  cation machin-
ery, living cells can form HS that lacks normal fi  ne structures 
but retains normal levels of sulfate groups and a considerable 
level of activity for growth factor signaling.
Numerous in vitro studies have identifi  ed various li-
gand proteins that bind to specifi  c sulfated HS sequences. 
  Recent studies using animal models have also highlighted the 
importance of distinct HS sulfation patterns for HSPG functions 
  (Bulow and Hobert, 2004). Thus, it is widely accepted that a 
specifi  c sequence of sulfation on HS determines a binding site 
for a ligand, enabling HSPGs to interact selectively with pro-
teins. However, it is not known how strictly ligand binding sites 
are defi  ned in vivo. Our study demonstrated that living cells 
show an unexpected level of fl  exibility in biosynthesis and func-
tion of HS. In vivo HS sulfation is fl  exible in two ways. First, 
HS modifi  cations can be adjusted in response to a defect in one 
type of   sulfation. Second, mutant HS chains thus synthesized, 
which do not contain normal sequences of sulfate groups but 
Figure 3.  Tracheal phenotypes and FGF-dependent MAPK activation in 
Hs2st; Hs6st double mutants. (A–I) Embryonic tracheal phenotypes in 
Hs2st; Hs6st zygotic double mutants. Note that these Hs2st; Hs6st double 
mutants received some maternal contribution of both gene products. 
  Embryonic tracheae were observed at stage 11 (A–C), 12 (D–F), and 
14 (G–I) using trh enhancer trap. (A, D, and G) Wild-type embryos. 
(B, C, E, F, H, and I) Zygotic Hs2st
d267; Hs6st
d770 double mutants. (J–M) 
MAPK activation in wild-type and Hs2st; Hs6st double mutants. Tracheal 
cells and MAPK activation were marked by trh enhancer trap (green) and 
anti–  diphospho-MAPK antibody (red), respectively, in wild-type (J and L) 
and the double mutant (K and M) embryos at stage 10 (J and K) and 12 
(L and M). (N–P) Tracheoblast phenotypes in Hs2st wing discs expressing 
Hs6st RNAi. Tracheoblasts in wing discs were labeled by expression 
of UAS-GFP driven by btl-Gal4 (N and O) or by trh enhancer trap (P). 
(N) Wild-type wing disc. (O) Hs2st
d267 UAS-GFP/Hs2st
d267; btl-Gal4/
UAS-IR-Hs6st wing disc. (P) Tracheoblasts (red) in Hs2st
d267 UAS-GFP/
Hs2st
d267; bnl-Gal4 1-eve-1/UAS-IR-Hs6st wing disc. Expression of bnl-Gal4 
is shown by GFP (green).FUNCTION OF 2-O AND 6-O SULFATED HS IN FGF SIGNALING • KAMIMURA ET AL. 777
bear normal levels of sulfation, do not completely lose core-
ceptor activity for growth factor signaling.
We found that Drosophila Hsst mutations induce com-
pensatory increases in sulfation at other positions, restoring a 
wild-type net charge on HS. Previously, Merry et al. (2001) 
showed that HS purifi  ed from Hs2st
−/− embryonic fi  broblasts 
did not have 2-O sulfate groups, but this loss was compensated 
for by increased N- and 6-O sulfation. This study suggested that 
a novel structure of HS found in the mutant HS may rescue 
some phenotypes of the Hs2st
−/− mice. Our study provides 
  evidence that the HS compensation indeed contributes to the 
modest phenotypes of animals defi  cient for these HS-modifying 
enzymes. The ability of the mutant HS to mediate signals is 
achieved, at least partly, by the sulfation compensation system 
because HS loses this ability when the compensation is blocked. 
These observations suggest that some in vivo roles of HS 
  require a suffi  cient amount of sulfate groups but not a strictly 
defi  ned placement on HS. This idea is supported by a recent 
biochemical study showing that binding of FGF to HS is 
  dictated primarily by charge density rather than by the precise 
positioning of various sulfate groups (Kreuger et al., 2005; 
  Jastrebova et al., 2006).
On the other hand, in different biological processes, spe-
cifi  c sequences play essential roles in generating specifi  city of 
HS–protein interaction. In particular, sulfation at the 3-O posi-
tion of the glucosamine residue, the rarest component of HS 
sulfation, is critically required for the binding site for anti-
thrombin III (HajMohammadi et al., 2003) and a coat glycopro-
tein of herpes simplex virus (Shukla et al., 1999). Collectively, 
the mechanism for in vivo HS–protein interactions may occur 
by several mechanisms: (1) some proteins bind specifi  c fi  ne 
structures; (2) some proteins are attracted to the charge on HS 
but have less strict structural requirements; and (3) some pro-
teins bind to HS based on a combination of specifi  c sequence 
and charge density. Further studies will defi  ne ligand proteins 
in each class as well as the nature of their binding to HS.
Materials and methods
Fly stocks
The detailed information for ﬂ  y strains used is described in Flybase (http://
ﬂ  ybase.bio.indiana.edu/), except where noted. All ﬂ  ies were maintained 
at 25°C. The following strains were used: Oregon-R, wild-type strain; 
P{GSV6}9303 (see the Drosophila Gene Search Project web site: http://
218.44.182.94/%7Edclust/) and P{lArB}A201.1M3, P-element insertion 
lines for Hs2st and Hs6st, respectively; Hs2st
d267 and Hs6st
d770, null   mutants 
for Hs2st and Hs6st, respectively (see below for mutant isolation); sﬂ  
9B4, a 
null allele of sﬂ  ; Df(2L)E55 (breakpoints, 37D02-E01; 37F05-38A01) and 
Df(3R)ora
I9 (breakpoints, 92B02-03; 92C02-03), chromosomal deﬁ  ciency 
lines; 1-eve-1, an enhancer trap line for the trachealess (trh) gene. The 
transgenic animals used were as follows: UAS-GFPnls; UAS-FLP; UAS-Sulf1 
(Sulf1 cDNA (SD04414, Berkeley Drosophila Genome Project) was fused 
to a 344-bp Sulf1 genomic PCR fragment to complete the coding region 
and inserted into pUAST vector); UAS-IR-Hs6st (see below for construction 
of  Hs6st transgenic RNAi ﬂ  ies);  nanos-Gal4;  actin-Gal4;  btl-Gal4; and 
bnl-Gal4 (strain number 2211; Drosophila Genetic Resource Center, Kyoto 
Institute of Technology, Japan).
Isolation of Hs2st and Hs6st mutants
To generate Hs2st
d267 and Hs6st
d770 mutants, P{GSV6}9303 and 
P{lArB}A201.1M3 were exposed to P element transposase from P{ry
+, ∆2-3} 
(99B). Their progeny were screened for loss of marker gene expression. 
Excision chromosomes were analyzed by PCR using ﬂ  anking primers to 
ﬁ  nd deletions, and the extent of each deletion was determined by sequenc-
ing PCR products that spanned the junction (see the legend to Fig. S1 for 
details). Lethality of Hs2st
d267 and Hs6st
d770 homozygotes (3.8% and 43%, 
respectively) was equivalent to that of their deﬁ  ciency transheterozygotes 
(Df(2L)E55/Hs2st
d267 and Df(3R)ora
I9/Hs6st
d770, respectively), indicating 
that these mutants are null alleles for each gene.
Generation of embryos lacking maternal and zygotic function 
of Hs2st and Hs6st
Embryos lacking maternal and zygotic activity of Hs2st were obtained 
by crossing Hs2st
d267 homozygous females to Hs2st
d267/CyO wg-lacZ 
males. To obtain Hs6st maternal and zygotic mutant embryos, germ 
line clones were generated using the autosomal FLP-DFS technique 
(Chou et al., 1993). Females carrying nanos-Gal4 UAS-FLP/+; FRT82B 
Hs6st
d770/FRT82B ovo
D1 were mated with Hs6st
d770/TM3 Sb ftz-lacZ. 
The resultant maternal and zygotic mutant embryos were identiﬁ  ed with 
marked balancer.
Construction of Hs6st transgenic RNAi ﬂ  ies
Transgenic RNAi ﬂ  ies  of  Hs6st were obtained as described previously 
(Kamimura et al., 2004). A 500-bp-long cDNA fragment from the ﬁ  rst 
Figure 4.  Overexpression of Sulf1 reduces the 
6-O sulfate groups on HS and causes tracheal 
defects. (A) HS disaccharide proﬁ  ling of wild-
type (black) and actin-Gal4/+; UAS-Sulf1/+ 
(blue) animals. (B) Tracheoblast phenotypes 
in wild-type and btl-Gal4 UAS-GFP/btl-Gal4; 
UAS-Sulf1 wing discs.JCB • VOLUME 174 • NUMBER 6 • 2006  778
  methionine was ampliﬁ  ed by PCR and inserted as an inverted repeat (IR) 
into a modiﬁ  ed pBluescript vector, pSC1, which possesses an IR formation 
site. IR-containing fragments were subcloned into pUAST, a transformation 
  vector, and transformation of Drosophila embryos was performed using 
w
1118 as a recipient strain.
Immunostaining and in situ RNA hybridization
Antibody staining was performed as described previously (Kamimura 
et al., 2004) using rabbit anti  –β-galactosidase (1:500; Cappel) and 
mouse anti-diphosphorylated MAP kinase (1:200; Sigma-Aldrich). The pri-
mary antibodies were detected with Alexa Fluor–conjugated secondary 
antibodies (1:500; Molecular Probes). For quantitative analysis of MAPK 
activation, the percentage of segments that show normal dpMAPK staining 
in tracheal precursor cells (stage 10 wild type, n = 12; stage 10 Hs2st; 
Hs6st, n = 18; stage 12 wild type, n = 27; and stage 12 Hs2st; Hs6st, 
n = 21) was calculated. In situ RNA hybridization was performed as 
  described previously (Kamimura et al., 2004). Light microscopy images 
were taken using a microscope (model BX50; Olympus) with a 40×/0.75 
UPlanFl objective by a CCD camera (DP-50; Olympus) controlled by Studio 
Lite software. Confocal imaging was performed using a microscope 
  (Axiovert 200M; Carl Zeiss MicroImaging, Inc.) with a 40×/0.75 Plan-
Neoﬂ   uar objective equipped with a confocal microscope system and a 
software (LCM5 PASCAL; Carl Zeiss MicroImaging, Inc.). Images were 
processed using Photoshop 7.0 (Adobe).
Preparation and HPLC analysis of HS disaccharides
HS disaccharide was analyzed by ﬂ  uorometric post-column HPLC as de-
scribed previously (Toyoda et al., 2000). Approximately 50 mg of lyophi-
lized adult ﬂ  ies was used to isolate HS. The HS sample was digested with 
a heparitinase mixture (Seikagaku) and subjected to a reversed-phase 
ion-pair chromatography.
Online supplemental material
Fig. S1 shows the molecular characterization of Hs2st and Hs6st mutants. 
Fig. S2 shows the quantitative analysis of MAPK activation and in situ 
RNA hybridization of bnl mRNA in wild-type and Hs2st
d267; Hs6st
d770 
embryos. Online supplemental material is available at http://www.jcb.
org/cgi/content/full/jcb.200603129/DC1.
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